Xiangyang Central Hospital ( Site 3123)

Xiangyang, Hubei 441106

1 studies enrolling now · 1 studies all time

What they study most

Breast Neoplasms

Studies at this site

• A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016) — Recruiting now